SCHEMBL7721206

SCHEMBL7721206

CCCc1ccnc2c(=O)[nH]c(-c3cc(S(=O)(=O)NC)ccc3OCC)nc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.66
PDE5A O76074 16/20 0.52
KMT2A Q03164 1/20 0.51
PDE2A O00408 2/20 0.50
PDE9A O76083 2/20 0.50
PDE4A P27815 2/20 0.50
PDE6C P51160 2/20 0.50
PDE1A P54750 2/20 0.50
PDE11A Q9HCR9 2/20 0.50
PDE10A Q9Y233 2/20 0.50
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
HIF1A Q16665 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MCOLN3 Q8TDD5 1/20 0.49
ABCC5 O15440 2/20 0.47
ABCC4 O15439 1/20 0.47
PDE6D O43924 1/20 0.47
PDE8A O60658 1/20 0.47
ABCB11 O95342 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8801494 0.83 PDE5A (0.58) KDM4EPDE5APDE2APDE9APDE4A
SCHEMBL8149898 0.83 PDE5A (0.70) PDE5APDE2APDE9APDE4APDE6C
SCHEMBL7721640 0.83 PDE5A (0.69) PDE5APDE2APDE9APDE4APDE6C
SCHEMBL7721903 0.82 PDE5A (0.73) KDM4EPDE5APDE2APDE9APDE4A
SCHEMBL7435920 0.82 PDE5A (0.51) KDM4EPDE5AKMT2APDE2APDE9A
SCHEMBL7444361 0.81 PDE5A (0.49) KDM4EPDE5AKMT2APDE2APDE9A
SCHEMBL7721655 0.81 PDE5A (0.47) KDM4EPDE5AKMT2APDE2APDE9A
SCHEMBL7718300 0.81 ABCC5 (0.47) KDM4EPDE5AKMT2APDE2APDE9A
SCHEMBL7440676 0.80 PDE5A (0.66) KDM4EPDE5AKMT2APDE2APDE9A
SCHEMBL3840503 0.79 PDE5A (0.72) PDE5APDE2APDE9APDE4APDE6C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6391885-B1 CONTROLLING APOPTOSIS IN AUTOIMMUNE DISEASE CELL PATHWAYS, INC. 2002-05-21 US disclosed
US-6060477-A Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives CELL PATHWAYS, INC. (US) 2000-05-09 US disclosed
EP-0656898-B1 PYRIDOPYRIMIDINONE ANTIANGINAL AGENTS PFIZER LTD (GB) 1997-01-22 EP disclosed
US-5591742-A TREATMENT OF ANGINA, HYPERTENSION, ATHEROSCLEROSIS, CARDIOVASCULAR DISORDERS PFIZER INC. (US) 1997-01-07 US disclosed